Morepen Laboratories Files First US ANDA for Sitagliptin
MM Desk
1 October, 2026
Morepen Laboratories Limited has submitted its first Abbreviated New Drug Application (ANDA) to the US
Morepen Laboratories Limited has submitted its first Abbreviated New Drug Application (ANDA) to the US
Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has commenced commercial supplies under its ₹825 crore
Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of an inspection
Morepen Laboratories Limited has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued